|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
|
Mineralys Therapeutics, Inc. (MLYS) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
| |
Company
Roster
|
|
Total
Insiders : |
8 |
|
|
|
Total
Direct Shares :
|
4,397,386 |
|
|
Total
Indirect Shares :
|
26,400,950 |
| |
%
Held by Insiders:
|
3.28% |
|
|
| |
| Filer's Name |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
  Rodman David Malcom |
Chief Medical Officer |
2025-06-13 |
101,651 |
2023-08-10 |
0 |
| Congleton Jon |
Chief Executive Officer, Director |
2025-04-11 |
862,289 |
|
0 |
| Levy Adam Scott |
CFO and Secretary |
2025-04-11 |
215,340 |
|
0 |
| Akkaraju Srinivas |
|
2024-02-12 |
0 |
2025-03-13 |
5,674,916 |
| Shah Rajeev M. |
Director |
2023-02-14 |
0 |
2025-03-13 |
6,147,280 |
| Samsara Biocapital, L.p. |
10% Owner |
2023-02-14 |
0 |
2025-03-13 |
5,674,916 |
| Hbm Bioventures Cayman Ltd |
10% Owner |
2023-02-14 |
3,218,106 |
2023-02-14 |
0 |
| Catalys Pacific Fund, Lp |
10% Owner |
|
0 |
2025-03-13 |
8,903,838 |
|
|
